NOVAVAX INC Stock-Based Compensation
NOVAVAX INC (NVAX) reported Stock-Based Compensation of $15.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- NOVAVAX INC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $8.09M, a 12.21% decline year-over-year.
- NOVAVAX INC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $7.72M, a 24.90% decline year-over-year.
- NOVAVAX INC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $7.97M, a 23.75% decline year-over-year.
- NOVAVAX INC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $8.55M, a 29.05% decline year-over-year.
- NOVAVAX INC share-based payment arrangement, noncash expense for fiscal 2025 was $36.02M, a 25.21% decline from fiscal 2024.
- NOVAVAX INC share-based payment arrangement, noncash expense for fiscal 2024 was $48.15M, a 43.59% decline from fiscal 2023.
- NOVAVAX INC share-based payment arrangement, noncash expense for fiscal 2023 was $85.36M, a 34.49% decline from fiscal 2022.
- NOVAVAX INC share-based payment arrangement, noncash expense for fiscal 2022 was $130.30M, a 29.04% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.81M 10-Q · filed 2026-08-06 | $23.78M derived: sum of 3 quarters · filed 2026-08-06 | $32.33M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $7.72M 10-Q · filed 2026-05-06 | $15.69M derived: sum of 2 quarters · filed 2026-05-06 | $24.24M derived: sum of 3 quarters · filed 2026-05-06 | $33.45M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.52M derived: sum of 2 quarters · filed 2026-02-26 | $25.73M derived: sum of 3 quarters · filed 2026-08-06 | $36.02M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.76M derived: sum of 2 quarters · filed 2026-08-06 | $28.05M 10-Q · filed 2025-11-06 | $38.50M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $19.50M 10-Q · filed 2026-08-06 | $29.95M derived: sum of 3 quarters · filed 2026-08-06 | $42.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $10.29M 10-Q · filed 2026-05-06 | $20.73M derived: sum of 2 quarters · filed 2026-05-06 | $32.78M derived: sum of 3 quarters · filed 2026-05-06 | $46.88M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $10.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.50M derived: sum of 2 quarters · filed 2026-02-26 | $36.60M derived: sum of 3 quarters · filed 2026-02-26 | $48.15M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $12.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $26.15M derived: sum of 2 quarters · filed 2025-11-06 | $37.70M 10-Q · filed 2025-11-06 | $53.36M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $25.66M 10-Q · filed 2025-08-06 | $41.31M derived: sum of 3 quarters · filed 2026-02-26 | $62.07M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $11.56M 10-Q · filed 2025-05-08 | $27.21M derived: sum of 2 quarters · filed 2026-02-26 | $47.97M derived: sum of 3 quarters · filed 2026-02-26 | $68.27M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $15.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.42M derived: sum of 2 quarters · filed 2026-02-26 | $56.71M derived: sum of 3 quarters · filed 2026-02-26 | $85.36M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $20.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $41.05M derived: sum of 2 quarters · filed 2024-11-12 | $69.70M 10-Q · filed 2024-11-12 | $97.47M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $20.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $48.94M 10-Q · filed 2024-08-08 | $76.71M derived: sum of 3 quarters · filed 2025-02-27 | $108.26M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $28.65M 10-Q · filed 2024-05-10 | $56.42M derived: sum of 2 quarters · filed 2025-02-27 | $87.97M derived: sum of 3 quarters · filed 2025-02-27 | $126.01M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $27.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $59.32M derived: sum of 2 quarters · filed 2025-02-27 | $97.37M derived: sum of 3 quarters · filed 2025-02-27 | $130.30M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $31.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $69.59M derived: sum of 2 quarters · filed 2023-11-09 | $102.53M 10-Q · filed 2023-11-09 | $134.69M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $38.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $70.98M 10-Q · filed 2023-08-08 | $103.15M derived: sum of 3 quarters · filed 2024-02-28 | $148.42M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $32.93M 10-Q · filed 2023-05-09 | $65.10M derived: sum of 2 quarters · filed 2024-02-28 | $110.38M derived: sum of 3 quarters · filed 2024-02-28 | $163.50M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $32.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $77.44M derived: sum of 2 quarters · filed 2024-02-28 | $130.57M derived: sum of 3 quarters · filed 2024-02-28 | $183.63M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $45.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $98.40M derived: sum of 2 quarters · filed 2022-11-09 | $151.46M 10-Q · filed 2022-11-09 | $201.89M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $53.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $106.18M 10-Q · filed 2022-08-09 | $156.62M derived: sum of 3 quarters · filed 2023-02-28 | $222.32M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $53.06M 10-Q · filed 2022-05-10 | $103.49M derived: sum of 2 quarters · filed 2023-02-28 | $169.20M derived: sum of 3 quarters · filed 2023-02-28 | $177.13M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $50.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $116.14M derived: sum of 2 quarters · filed 2023-02-28 | $124.07M derived: sum of 3 quarters · filed 2023-02-28 | $128.03M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $65.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $73.64M derived: sum of 2 quarters · filed 2021-11-05 | $77.60M 10-Q · filed 2021-11-05 | $81.85M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $7.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $11.90M 10-Q · filed 2021-08-05 | $16.14M derived: sum of 3 quarters · filed 2022-03-01 | $18.77M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $3.96M 10-Q · filed 2021-05-10 | $8.21M derived: sum of 2 quarters · filed 2022-03-01 | $10.83M derived: sum of 3 quarters · filed 2022-03-01 | $15.46M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.87M derived: sum of 2 quarters · filed 2022-03-01 | $11.49M derived: sum of 3 quarters · filed 2022-03-01 | $17.05M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $7.25M derived: sum of 2 quarters · filed 2020-11-10 | $12.80M 10-Q · filed 2020-11-10 | $17.19M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $10.18M 10-Q · filed 2020-08-10 | $14.56M derived: sum of 3 quarters · filed 2021-03-01 | $19.00M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $5.56M 10-Q · filed 2020-05-11 | $9.94M derived: sum of 2 quarters · filed 2021-03-01 | $14.38M derived: sum of 3 quarters · filed 2021-03-01 | $18.63M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $8.82M derived: sum of 2 quarters · filed 2021-03-01 | $13.07M derived: sum of 3 quarters · filed 2021-03-01 | $18.31M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $8.68M derived: sum of 2 quarters · filed 2019-11-07 | $13.93M 10-Q · filed 2019-11-07 | $13.93M 10-Q · filed 2018-11-07 | $20.68M derived: sum of 4 quarters · filed 2020-03-11 | |
| 2018-06-30 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $9.50M 10-Q · filed 2019-08-07 | $9.50M 10-Q · filed 2018-08-08 | $16.25M derived: sum of 3 quarters · filed 2020-03-11 | $20.58M derived: sum of 4 quarters · filed 2020-03-11 | |
| 2018-03-31 | $5.25M 10-Q · filed 2019-05-02 | $12.00M derived: sum of 2 quarters · filed 2020-03-11 | $16.33M derived: sum of 3 quarters · filed 2020-03-11 | $20.84M derived: sum of 4 quarters · filed 2020-03-11 | ||
| 2017-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $11.08M derived: sum of 2 quarters · filed 2020-03-11 | $15.60M derived: sum of 3 quarters · filed 2020-03-11 | $19.81M 10-K · filed 2020-03-11 | ||
| 2017-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.84M derived: sum of 2 quarters · filed 2018-11-07 | $13.06M 10-Q · filed 2018-11-07 | $16.84M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $8.73M 10-Q · filed 2018-08-08 | $12.51M derived: sum of 3 quarters · filed 2019-03-18 | $17.67M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-03-31 | $4.21M 10-Q · filed 2018-05-09 | $7.99M derived: sum of 2 quarters · filed 2019-03-18 | $13.15M derived: sum of 3 quarters · filed 2019-03-18 | $18.41M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $8.94M derived: sum of 2 quarters · filed 2019-03-18 | $14.20M derived: sum of 3 quarters · filed 2019-03-18 | $19.16M 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $10.42M derived: sum of 2 quarters · filed 2017-11-07 | $15.38M 10-Q · filed 2017-11-07 | $19.53M derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-06-30 | $5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $10.22M 10-Q · filed 2017-08-08 | $14.37M derived: sum of 3 quarters · filed 2018-03-14 | $19.14M derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-03-31 | $4.96M 10-Q · filed 2017-05-08 | $9.11M derived: sum of 2 quarters · filed 2018-03-14 | $13.88M derived: sum of 3 quarters · filed 2018-03-14 | $16.46M derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2015-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $8.92M derived: sum of 2 quarters · filed 2018-03-14 | $11.50M derived: sum of 3 quarters · filed 2018-03-14 | $13.43M 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $4.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $7.35M derived: sum of 2 quarters · filed 2016-11-09 | $9.28M 10-Q · filed 2016-11-09 | $10.79M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.51M 10-Q · filed 2016-08-09 | $6.02M derived: sum of 3 quarters · filed 2017-02-27 | $7.71M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | $1.93M 10-Q · filed 2016-05-05 | $3.44M derived: sum of 2 quarters · filed 2017-02-27 | $5.13M derived: sum of 3 quarters · filed 2017-02-27 | $6.98M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $3.20M derived: sum of 2 quarters · filed 2017-02-27 | $5.05M derived: sum of 3 quarters · filed 2017-02-27 | $6.09M 10-K · filed 2017-02-27 | ||
| 2014-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.54M derived: sum of 2 quarters · filed 2015-11-09 | $4.58M 10-Q · filed 2015-11-09 | $5.28M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.89M 10-Q · filed 2015-08-10 | $3.59M derived: sum of 3 quarters · filed 2016-02-29 | $4.25M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $1.04M 10-Q · filed 2015-05-07 | $1.74M derived: sum of 2 quarters · filed 2016-02-29 | $2.40M derived: sum of 3 quarters · filed 2016-02-29 | $3.04M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.36M derived: sum of 2 quarters · filed 2016-02-29 | $2.00M derived: sum of 3 quarters · filed 2016-02-29 | $2.48M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.30M derived: sum of 2 quarters · filed 2014-11-06 | $1.78M 10-Q · filed 2014-11-06 | $2.21M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $638.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.12M 10-Q · filed 2014-08-07 | $1.54M derived: sum of 3 quarters · filed 2015-02-27 | $2.04M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $483.00K 10-Q · filed 2014-05-08 | $906.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.40M derived: sum of 3 quarters · filed 2015-02-27 | $1.99M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $915.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.50M derived: sum of 3 quarters · filed 2015-02-27 | $2.09M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.08M derived: sum of 2 quarters · filed 2013-11-12 | $1.67M 10-Q · filed 2013-11-12 | $2.04M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.18M 10-Q · filed 2013-08-08 | $1.55M derived: sum of 3 quarters · filed 2014-03-12 | $2.09M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-03-31 | $587.00K 10-Q · filed 2013-05-09 | $957.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.50M derived: sum of 3 quarters · filed 2014-03-12 | $2.20M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2011-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $912.00K derived: sum of 2 quarters · filed 2014-03-12 | $1.61M derived: sum of 3 quarters · filed 2014-03-12 | $2.05M 10-K · filed 2014-03-12 | ||
| 2011-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.25M derived: sum of 2 quarters · filed 2012-11-09 | $1.68M 10-Q · filed 2012-11-09 | $1.88M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-06-30 | $703.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.14M 10-Q · filed 2012-08-09 | $1.33M derived: sum of 3 quarters · filed 2013-03-12 | $1.97M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-03-31 | $432.00K 10-Q · filed 2012-05-09 | $630.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.26M derived: sum of 3 quarters · filed 2013-03-12 | |||
| 2010-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $830.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.34M 10-K · filed 2013-03-12 | |||
| 2010-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.14M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $509.00K 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $1.53M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |